As of 2026-03-18, the Relative Valuation of THC Biomed Intl Ltd (THC.CN) is (0.21) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.02 CAD, the upside of THC Biomed Intl Ltd based on Relative Valuation is -1169.4%.
The range of the Relative Valuation is (0.22) - (0.23) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 3.7x - 5.1x | 4.4x |
| Forward P/E multiples | 5.0x - 5.3x | 5.2x |
| Fair Price | (0.22) - (0.23) | (0.21) |
| Upside | -1219.8% - -1233.2% | -1169.4% |
| Date | P/E |